Weekly docetaxel (TXT) and cisplatin (CIS) for chemonaive patients (Pts) with advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Aisner, J [1 ]
Geunsch, L [1 ]
Schwarz, S [1 ]
Zheng, L [1 ]
Wojtaszek, C [1 ]
Lutzker, S [1 ]
机构：
[1] Canc Inst New Jersey, New Brunswick, NJ USA
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S233 / S233
页数：1
相关论文
共 50 条
  • [1] A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC)
    Sovak, M. A.
    Lutzker, S.
    Guensch, L.
    Joyce, M.
    Schwartz, S.
    Wu, Y.
    Zheng, L.
    Aisner, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Cobolimab With Dostarlimab and Docetaxel in Patients (pts) With Advanced Non-small Cell Lung Cancer (NSCLC): COSTAR Lung
    Kim, Hye Ryun
    Gridelli, Cesare
    Kapur, Dinesh
    Tufman, Amanda
    Felip, Enriqueta
    Velcheti, Vamsidhar
    Kim, Yu Jung
    Goetze, Thorsten
    Lopez, Pilar Garrido
    Corre, Romain
    Penkov, Konstantin
    Anjum, Rana
    Di Pace, Brian
    Liu, Wenlei
    Borgovan, Theo
    Ledger, Danielle
    Carver, Jennifer
    Waszak, Angela
    Dhar, Arindam
    Novello, Silvia
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 163 - 163
  • [3] Biweekly docetaxel (Doc) followed by gemcitabine (Gem) and cisplatin (Cis) in patients (pts) with advanced non-small cell lung cancer (NSCLC): A clinical proteomic study
    De Castro, J.
    Belda-Iniesta, C.
    Casado Saenz, E.
    Feliu Batlle, J.
    Sereno Moyano, M.
    Gomez Raposo, C.
    Pinto Marin, A.
    Alvar, J.
    Gonzalez-Baron, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Our expreience with cisplatin plus weekly docetaxel in patients with advanced non-small cell lung cancer
    Tartarone, Alfredo
    Romano, Gianpiero
    Coccaro, Mariarosa
    Capobianco, Alba
    Bochicchio, Annamaria
    Di Leo, Pasquale
    Iodice, Giovanni
    Mele, Giuseppe
    Matera, Rosella
    Di Renzo, Nicola
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 180 - 180
  • [5] A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC)-Final report
    Sovak, M. A.
    Guensch, L.
    Joyce, P.
    Lutzker, S. G.
    Schwartz, S.
    Shih, W. J.
    Zheng, L.
    Aisner, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] A phase II study of nedaplatin (CDGP) and docetaxel (TXT) in patients with advanced non-small cell lung cancer (NSCLC)
    Fujino, S.
    Asada, Y.
    Nakano, Y.
    Suzumura, Y.
    Inoue, S.
    Nagao, T.
    Hajiro, T.
    Tezuka, N.
    Sawai, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Phase II and pharmacogenetic study of docetaxel (D) and capecitabine (C) in chemonaive non-small cell lung cancer (NSCLC) patients (pts)
    Lustberg, M. B.
    Bekaii-Saab, T. S.
    Diasio, R.
    Ezzeldin, H.
    Starrett, S. L.
    Otterson, G. A.
    Villalona, M. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Weekly administration of gemcitabine plus docetaxel in advanced non-small cell lung cancer (NSCLC).
    Sun, Y
    Li, J
    Wu, Y
    Li, L
    Gu, L
    Zhang, L
    Wang, J
    Zhang, X
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 698S - 698S
  • [9] A phase I study of weekly docetaxel and cisplatin in advanced non-small cell lung cancer
    Sato, K
    Tsuchiya, S
    Minato, K
    Takei, Y
    Watanabe, S
    Saitoh, R
    Mori, M
    [J]. LUNG CANCER, 2001, 33 (01) : 69 - 73
  • [10] Celecoxib (CEL) and weekly docetaxel (DOC) in elderly or PS2 patients (pts) with advanced non-small cell lung cancer (NSCLC).
    Chaplan, RA
    Kalemkerian, GP
    Wozniak, A
    Shehadeh, N
    Ruckdeschel, JC
    Kraut, MJ
    Heilbrun, L
    Parchment, R
    Gadgeel, SM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 641S - 641S
12345